RM

Rocio Reategui MD

Medical Monitor and Clinical Development Consultant at QED Therapeutics

Rocio Reategui MD is an experienced medical professional specializing in oncology, currently serving as a Medical Monitor and Clinical Development Consultant at QED Therapeutics since March 2022 and as a Medical Director at Medical Monitoring Solutions since July 2020. Previously, Rocio held various positions in notable organizations, including Medical Advisor roles at Roche and Pfizer, and served as a Medical Oncologist and Principal Investigator at Instituto Oncologico de Lima and Edgardo Rebagliati Martins National Hospital. Rocio's educational background includes a Master in Molecular Oncology from the Spanish National Cancer Research Center and a degree in Medical Oncology and Medical Doctor (MD) from Federico Villarreal National University.

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


QED Therapeutics

QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. They plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.


Industries

Employees

11-50

Links